Charles River Laboratories | 营业费用

股票价格
189.21
每天变化
5.51 3.00%
每月一次
-12.71%
每年
15.52%
Q1 预测
183.40


金融业
股票价格
USD
资产
USD 7.51B
现金及等价物
USD 207.1M
销售成本
USD 693.46M
流动资产
USD 1.53B
流动负债
USD 1.12B
债务
USD 2.79B
EBIT
USD 133.8M
EBITDA
USD 282.89M
员工
18.6K
EPS每股收益
USD 2.43
股本和储备
USD 3.41B
销售毛利
USD 311.39M
债务利息支出
USD 25.4M
利息收入
USD 1.1
贷款资金
USD 2.19B
市值
USD 9.36B
净收入
USD 54.42M
营业费用
USD 3.41B
营业利润
USD 133.8M
普通股股本
USD 49.22M
PE价格收益
USD 42.72
税前利润
USD 170.03M
销售收入
USD 1B
销售和管理费用
USD 177.59M
股票
USD 302.55M
贸易债权人
USD 169.62M
应收帐款人
USD 1.48B


营业费用 更改 日
Agilent USD 1.42B 57M 2025-09
Align Technology USD 822.85M 11.8M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 776.6M 8.9M 2025-09
Cardinal Health USD -2.88B 5M 2025-12
Charles River Laboratories USD 3.41B 2.51B 2025-09
Cigna USD 41.8B 23.4B 2025-09
CVS Health USD 99.92B 4.3B 2025-09
Danaher USD 5.34B 45.74B 2025-12
Dentsply International USD 1.48B 653M 2025-09
Elevance Health USD 49.17B 5.21B 2025-12
Galapagos EUR 112.83M 9.48M 2025-09
Hologic USD 349.4M 447.1M 2025-12
Humana USD 32.25B 959M 2025-09
Illumina USD 903M 69M 2025-12
Incyte USD 4.65B 3.75B 2025-09
IQVIA Holdings USD 1.69B 4.47B 2025-12
Laboratory Of America USD 3.17B 101.7M 2025-09
Lonza CHF 3.09B 564M 2024-12
McKesson USD 104.5B 2.85B 2025-12
Merck EUR 4.11B 117M 2025-09
Mettler Toledo International USD 777.8M 42.3M 2025-12
Novartis USD 9.86B 115M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Quest Diagnostics USD 7.26B 4.94B 2025-09
Revvity USD 600.61M 12.7M 2025-09
Thermo Fisher Scientific USD 9.91B 867M 2025-12
United Therapeutics USD 6.59B 6.07B 2025-09
UnitedHealth USD 109.96B 1.11B 2025-12
Waters USD 2.33B 1.75B 2025-09
West Pharmaceutical Services USD 3.05B 2.44B 2025-09


Charles River Laboratories 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.